Is the drug pipeline really drying up?
This week we’ll hear why Donald Light, professor of comparative health systems research at the University of Medicine and Dentistry of New Jersey, thinks the innovation crisis in the development of drugs is more marketing rhetoric than reality.
Also this week, a research paper on bmj.com looks at how subclinical psychological distress affects mortality. Tom Russ, Alzheimer Scotland clinical research fellow at the University of Edinburgh and one of the paper's authors, explains what they found.
See also
Association between psychological distress and mortality
Pharmaceutical research and development: what do we get for all that money?
Audio chapters:
Psychological distress and mortality: 0:37
Innovation crisis: 9:34








Re: Better management of patients with multimorbidity
Published 17 May 2013
Re: India must raise the status of primary care
Published 17 May 2013
Re: Partnering with patients
Published 17 May 2013
Re: Rescue boards are set up in England to deal with “significant deterioration” in A&E departments
Published 17 May 2013